
Jason S. Morrow
Examiner (ID: 12308, Phone: (571)272-6663 , Office: P/3612 )
| Most Active Art Unit | 3612 |
| Art Unit(s) | 3612 |
| Total Applications | 2666 |
| Issued Applications | 2217 |
| Pending Applications | 153 |
| Abandoned Applications | 325 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11059567
[patent_doc_number] => 20160256529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/063227
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7233
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/063227 | COMBINATION THERAPY | Mar 6, 2016 | Abandoned |
Array
(
[id] => 10980043
[patent_doc_number] => 20160176987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/057967
[patent_app_country] => US
[patent_app_date] => 2016-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26076
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15057967
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/057967 | METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT | Feb 29, 2016 | Abandoned |
Array
(
[id] => 10820484
[patent_doc_number] => 20160166648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'Treatment of Multiple Sclerosis With Combination of Laquinimod and Interferon-Beta'
[patent_app_type] => utility
[patent_app_number] => 15/050005
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19421
[patent_no_of_claims] => 204
[patent_no_of_ind_claims] => 66
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050005
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050005 | Treatment of Multiple Sclerosis With Combination of Laquinimod and Interferon-Beta | Feb 21, 2016 | Abandoned |
Array
(
[id] => 10813755
[patent_doc_number] => 20160159916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'METHOD OF TREATING DIABETES, AND DISEASES ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE'
[patent_app_type] => utility
[patent_app_number] => 15/041582
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2269
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041582
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041582 | METHOD OF TREATING DIABETES, AND DISEASES ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE | Feb 10, 2016 | Abandoned |
| 15/019000 | Method of Preventing and Treating Retinal Microvasculature Inflammation Using C-Met Signaling Pathway Inhibition | Feb 8, 2016 | Abandoned |
Array
(
[id] => 12428322
[patent_doc_number] => 09975948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
[patent_app_type] => utility
[patent_app_number] => 15/000831
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 7
[patent_no_of_words] => 29799
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15000831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/000831 | Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography | Jan 18, 2016 | Issued |
Array
(
[id] => 12997563
[patent_doc_number] => 10022427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Interferon lambda-antibody complexes
[patent_app_type] => utility
[patent_app_number] => 14/997843
[patent_app_country] => US
[patent_app_date] => 2016-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30542
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14997843
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/997843 | Interferon lambda-antibody complexes | Jan 17, 2016 | Issued |
Array
(
[id] => 10799193
[patent_doc_number] => 20160145350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'ANTIBODIES AGAINST CD73 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/994828
[patent_app_country] => US
[patent_app_date] => 2016-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 87
[patent_no_of_words] => 91362
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14994828
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/994828 | Antibodies against CD73 | Jan 12, 2016 | Issued |
Array
(
[id] => 12808657
[patent_doc_number] => 20180161389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => R-SPONDIN AGONIST-MEDIATED HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 15/540865
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540865
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540865 | R-SPONDIN AGONIST-MEDIATED HAIR GROWTH | Jan 7, 2016 | Abandoned |
Array
(
[id] => 10978516
[patent_doc_number] => 20160175458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'SINGLE CHAIN FC FUSION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/974114
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19946
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14974114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/974114 | SINGLE CHAIN FC FUSION PROTEINS | Dec 17, 2015 | Abandoned |
Array
(
[id] => 13968297
[patent_doc_number] => 10213482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Methods of treating chronic inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 14/966679
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 35
[patent_no_of_words] => 27062
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966679
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/966679 | Methods of treating chronic inflammatory diseases | Dec 10, 2015 | Issued |
Array
(
[id] => 13077073
[patent_doc_number] => 10058591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer
[patent_app_type] => utility
[patent_app_number] => 14/958485
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5589
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14958485
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/958485 | Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer | Dec 2, 2015 | Issued |
Array
(
[id] => 10988898
[patent_doc_number] => 20160185843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'TREATING ALCOHOL-MEDIATED DISORDERS BY INHIBITION OF RGS6'
[patent_app_type] => utility
[patent_app_number] => 14/952747
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16457
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14952747
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/952747 | Treating alcohol-mediated disorders by inhibition of RGS6 | Nov 24, 2015 | Issued |
Array
(
[id] => 10981700
[patent_doc_number] => 20160178644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/944147
[patent_app_country] => US
[patent_app_date] => 2015-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35052
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14944147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/944147 | METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE | Nov 16, 2015 | Abandoned |
Array
(
[id] => 10755005
[patent_doc_number] => 20160101157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN'
[patent_app_type] => utility
[patent_app_number] => 14/936228
[patent_app_country] => US
[patent_app_date] => 2015-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6620
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14936228
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/936228 | METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN | Nov 8, 2015 | Abandoned |
Array
(
[id] => 10774791
[patent_doc_number] => 20160120948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'IL-12 COMPOSITIONS AND METHODS OF USE IN HEMATOPOIETIC RECOVERY'
[patent_app_type] => utility
[patent_app_number] => 14/928439
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29767
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14928439
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/928439 | IL-12 COMPOSITIONS AND METHODS OF USE IN HEMATOPOIETIC RECOVERY | Oct 29, 2015 | Abandoned |
Array
(
[id] => 13803803
[patent_doc_number] => 10179162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Citrate free pharmaceutical compositions comprising anakinra
[patent_app_type] => utility
[patent_app_number] => 14/926438
[patent_app_country] => US
[patent_app_date] => 2015-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4996
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14926438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/926438 | Citrate free pharmaceutical compositions comprising anakinra | Oct 28, 2015 | Issued |
Array
(
[id] => 11047561
[patent_doc_number] => 20160244519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'ANTIBODIES TO M-CSF'
[patent_app_type] => utility
[patent_app_number] => 14/923655
[patent_app_country] => US
[patent_app_date] => 2015-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 39553
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14923655
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/923655 | Antibodies to M-CSF | Oct 26, 2015 | Issued |
Array
(
[id] => 10722466
[patent_doc_number] => 20160068612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B'
[patent_app_type] => utility
[patent_app_number] => 14/922282
[patent_app_country] => US
[patent_app_date] => 2015-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 43177
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14922282
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/922282 | Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B | Oct 25, 2015 | Issued |
Array
(
[id] => 10769091
[patent_doc_number] => 20160115247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/922081
[patent_app_country] => US
[patent_app_date] => 2015-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25874
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14922081
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/922081 | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS | Oct 22, 2015 | Abandoned |